leukotriene-e4 and Vascular-Diseases

leukotriene-e4 has been researched along with Vascular-Diseases* in 1 studies

Other Studies

1 other study(ies) available for leukotriene-e4 and Vascular-Diseases

ArticleYear
Urinary cysteinyl leukotriene E(4) is associated with increased risk for pain and acute chest syndrome in adults with sickle cell disease.
    American journal of hematology, 2009, Volume: 84, Issue:3

    Leukotriene E(4) (LTE(4)) levels are associated with rate of pain episodes in children with sickle cell disease (SCD). Because complications of SCD manifest differently in adults than children, we examined a cohort of adults with SCD to determine the relationship between baseline LTE(4) and SCD-related morbidity. Baseline LTE(4) levels were associated with increased rates of pain and acute chest syndrome (ACS) episodes, when those with LTE(4) values in the highest tertile were compared with those in the lowest tertile (pain: risk ratio 7.1, 95% CI 1.8-27.5, P = 0.005; ACS: risk ratio 12.2, 95% CI 2.1-69.8, P = 0.005).

    Topics: Adult; Anemia, Sickle Cell; Case-Control Studies; Female; Humans; Leukotriene E4; Male; Pain; Vascular Diseases; Young Adult

2009